Wendy S. Johnson

Insider Reports History

Entity
Individual
Location
800 E. Leigh Street, Suite 209, Richmond, VA
Signature
/s/ Kamal Adawi, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Wendy S. Johnson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
EXAGEN INC. Director Stock Option(right to buy) 9K Jun 9, 2023 Direct
Reneo Pharmaceuticals, Inc. Chief Development Officer Common Stock 0 $6.28 Jul 14, 2021 Direct

Insider Reports Filed by Wendy S. Johnson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XGN EXAGEN INC. Jun 9, 2023 1 $0 4 Jun 13, 2023 Director
XGN EXAGEN INC. Jun 16, 2022 1 $0 4 Jun 21, 2022 Director
XGN EXAGEN INC. Sep 3, 2021 1 $14K 4 Sep 7, 2021 Director
RPHM Reneo Pharmaceuticals, Inc. Jul 14, 2021 1 -$950K 4 Jul 15, 2021 Chief Development Officer
RPHM Reneo Pharmaceuticals, Inc. Jul 8, 2021 2 $220K 4 Jul 9, 2021 Chief Development Officer
XGN EXAGEN INC. Jun 17, 2021 1 $0 4 Jun 21, 2021 Director